A detailed history of Janus Henderson Group PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 976,329 shares of CYTK stock, worth $56.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
976,329
Previous 797,372 22.44%
Holding current value
$56.6 Million
Previous $55.9 Million 5.38%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $8.56 Million - $13.4 Million
178,957 Added 22.44%
976,329 $52.9 Million
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $113 Million - $191 Million
-1,771,033 Reduced 68.95%
797,372 $55.9 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $2.02 Million - $6.27 Million
75,079 Added 3.01%
2,568,405 $214 Million
Q3 2023

Nov 14, 2023

BUY
$29.46 - $36.61 $11.7 Million - $14.6 Million
397,627 Added 18.97%
2,493,326 $73.5 Million
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $17 Million - $21.3 Million
522,055 Added 33.17%
2,095,699 $68.4 Million
Q1 2023

May 15, 2023

BUY
$33.36 - $45.71 $46.7 Million - $64 Million
1,399,714 Added 804.76%
1,573,644 $55.4 Million
Q4 2022

Feb 14, 2023

BUY
$35.77 - $51.11 $5.69 Million - $8.12 Million
158,967 Added 1062.4%
173,930 $7.97 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $809 - $1,144
21 Added 0.14%
14,963 $725,000
Q2 2022

Aug 15, 2022

SELL
$33.93 - $48.92 $203 - $293
-6 Reduced 0.04%
14,942 $587,000
Q1 2022

May 16, 2022

BUY
$29.74 - $46.0 $118 - $184
4 Added 0.03%
14,948 $550,000
Q4 2021

Feb 14, 2022

BUY
$34.35 - $46.38 $258,586 - $349,148
7,528 Added 101.51%
14,944 $682,000
Q3 2021

Nov 16, 2021

BUY
$18.54 - $35.74 $137,492 - $265,047
7,416 New
7,416 $265,000
Q4 2017

Feb 09, 2018

SELL
$7.25 - $15.65 $20.1 Million - $43.5 Million
-2,778,605 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$12.0 - $15.0 $1.12 Million - $1.41 Million
93,675 Added 3.49%
2,778,605 $0
Q2 2017

Aug 17, 2017

BUY
N/A
2,684,930
2,684,930 $32.5 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $5.46B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.